Worldwide, at least seven people have been "cured" of HIV—or at least have had long-term sustained remission. This means that ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

The State Department is taking over programs previously run by the U.S. Agency for International Development, also known as ...

The COVID-19 pandemic paused many HIV prevention efforts, which helped fuel last year's rise in new infections. President ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...

It reduces transmissions by up to 96%, but now world governments and big-dollar funders will need to step in.